טוען...
An NKT-mediated autologous vaccine generates CD4 T-cell–dependent potent antilymphoma immunity
Relapses occurring in most patients with lymphoma after antibody or chemotherapy highlight a need for effective vaccination approaches. Autologous tumors are ideal sources of patient-specific tumor antigens for vaccines; however, their poor immunogenicity has been a major obstacle in practice. Natur...
שמור ב:
| Main Authors: | , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
American Society of Hematology
2007
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1976361/ https://ncbi.nlm.nih.gov/pubmed/17581919 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2006-12-061309 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|